PubMed · 1984 · 80 citations · 11 references
MedicineOncologyPharmacologyCancer PharmacologyGastrointestinal OncologyNeoplasiaGastric CancerMalignant NeoplasmsOncology PharmacologyTumor PromotionCamp-protein Kinase A SignalingCyclic Adenosine Monophosphate PathwayCyclic Adenosine Monophosphate SignalingGastrin SecretionRodent Tumor ModelsTumor Growth DynamicsTumor Growth RateWell-differentiated Tumors
This study deals with the growth effect of gastrin on two xenotransplantable human gastric carcinomas (SC-6-JCK, poorly differentiated adenocarcinoma; and St-15, mucinous adenocarcinoma) and on one colonic carcinoma (Co-3, well-differentiated adenocarcinoma). In SC-6-JCK, the treatment with s.c. injection of pentagastrin at a dose of 10 micrograms/mouse once daily for 25 days promoted the growth of the tumor transplanted in nude mice, but gastrin had no effect at all on St-15 and Co-3. In SC-6-JCK, the weight, size, and labeling index of [3H]thymidine of the tumor were significantly increased in comparison with those of the control (p less than 0.05). In SC-6-JCK, cyclic adenosine 3':5'-monophosphate (cAMP) in the tumor was increased by a single i.p. injection of pentagastrin at a dose of 20 micrograms/mouse in nude mice, but such an increase was not observed in St-15 and Co-3. Cyclic guanosine 3':5'-monophosphate in SC-6-JCK was slightly increased by gastrin treatment but was not affected in the other tumors. In SC-6-JCK, at 30 min after gastrin treatment when cAMP showed a maximum increase, the activity ratio of cAMP-dependent protein kinase in the tumor was also elevated. In vitro also, gastrin stimulated cAMP production and cAMP-dependent protein kinase activation. The data suggest that some human gastric carcinomas may have receptor for gastrin.
11
An improved fluorometric assay for DNA
Ralph T. Hinegardner · Analytical Biochemistry · 1971 · 989 citations
John P. MacManus, B. Braceland, T. Youdale et al. · Journal of Cellular Physiology · 1973 · 144 citations